BridgeMD
The effect of suprainguinal fascia iliaca compartment block
EU CTIS ID: 2023-510388-37-00
What this study is testing
To investigate the frequency of anesthesia of the obturator nerve after subpectineal obturator nerve blockade (SOB) vs. suprainguinal fascia iliaca compartment block (SIFICB) in healthy volunteers.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- American Society of Anesthesiologists physical status classification score (ASA) I-II
- Age ≥ 18 years
- BMI < 25 kg/m²
- Able to read and understand Danish as well as read, understand and sign informed written consent
- Weight ≥ 69 kg
You likely can't join if
- Inability to cooperate
- Decreased sense of touch on the lower extremities assessed by examination by the investigator before the start of the trial
- Known coagulopathy
- Infection in the areas of insertion sites for nerve blocks and EMG examination
- Allergy to local analgesics used in the study (Ropivacaine)
- Allergy to contrast agents for MR scanning (Gadoteric acid)
See the full eligibility criteria
- American Society of Anesthesiologists physical status classification score (ASA) I-II
- Age ≥ 18 years
- BMI < 25 kg/m²
- Able to read and understand Danish as well as read, understand and sign informed written consent
- Weight ≥ 69 kg
- Inability to cooperate
- Decreased sense of touch on the lower extremities assessed by examination by the investigator before the start of the trial
- Known coagulopathy
- Infection in the areas of insertion sites for nerve blocks and EMG examination
- Allergy to local analgesics used in the study (Ropivacaine)
- Allergy to contrast agents for MR scanning (Gadoteric acid)
- Daily medication consumption besides oral contraception
- Abuse of alcohol, drugs or medication
- Pregnancy
- Unable to speak and understand Danish
- Fear of needles
- Claustrophobia
- Metallic implants in the body incl. pacemaker
- Known reduced kidney function
- Known reduced liver function
- Previously operated on in the hip area or groin
- Known neuropathy in the lower extremities
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.